These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22765638)

  • 1. Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcome.
    Faradji A; Lavigne-Lissalde G; Grunebaum L; Desprez D; Feugeas O; Lapalud P
    Haemophilia; 2012 Sep; 18(5):e388-91. PubMed ID: 22765638
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergenic vaccines administration and inhibitor development in haemophilia.
    Bermejo N; Martín Aguilera C; Carnicero F; Bergua J
    Haemophilia; 2012 Sep; 18(5):e392-3. PubMed ID: 22672147
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor.
    Rivolta GF; Di Perna C; Franchini M; Riccardi F; Ippolito L; Lombardi M; Tagliaferri A
    Blood Transfus; 2010 Jan; 8(1):66-8. PubMed ID: 20104281
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach.
    Mannucci PM; Abshire T; Dimichele D; Santagostino E; Blanchette V
    Haemophilia; 2006 Jul; 12(4):429-34. PubMed ID: 16834746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].
    Wu RH; Wei QQ
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):631-4. PubMed ID: 24225299
    [No Abstract]   [Full Text] [Related]  

  • 6. International workshop on immune tolerance induction: consensus recommendations.
    DiMichele DM; Hoots WK; Pipe SW; Rivard GE; Santagostino E
    Haemophilia; 2007 Jul; 13 Suppl 1():1-22. PubMed ID: 17593277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.
    van Helden PM; Kaijen PH; Mauser-Bunschoten EP; Fischer K; van den Berg HM; Voorberg J
    Haemophilia; 2010 Nov; 16(6):892-901. PubMed ID: 20491952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
    Rangarajan S; Jiménez-Yuste V; Santagostino E
    Haemophilia; 2014 Nov; 20(6):e414-7. PubMed ID: 25333452
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab.
    Zhang X; Guo J; Guo X; Pan J
    Haemophilia; 2012 Sep; 18(5):e393-5. PubMed ID: 22823057
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary report of the First International Conference on inhibitors in haemophilia A.
    Lacroix-Desmazes S; Scott DW; Goudemand J; Van Den Berg M; Makris M; Van Velzen AS; Santagostino E; Lillicrap D; Rosendaal FR; Hilger A; Sauna ZE; Oldenburg J; Mantovani L; Mancuso ME; Kessler C; Hay CRM; Knoebl P; Di Minno G; Hoots K; Bok A; Brooker M; Buoso E; Mannucci PM; Peyvandi F
    Blood Transfus; 2017 Oct; 15(6):568-576. PubMed ID: 27893354
    [No Abstract]   [Full Text] [Related]  

  • 11. A child with acquired haemophilia.
    Somaratne PD; Jansan J; Senanayake HM; Ratnamalala V; Jayathilake MM; Thirumavalavan K
    Ceylon Med J; 2014 Jun; 59(2):66-7. PubMed ID: 24977427
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A.
    Ranta S; Koskinen S; Mäkipernaa A
    Haemophilia; 2011 Sep; 17(5):e833-4. PubMed ID: 21624011
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemophilia A and inhibitors: advances in prevention and ITI treatment optimization.
    Kruse-Jarres R
    Haemophilia; 2014 Sep; 20 Suppl 6():1. PubMed ID: 24975699
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel therapies for immune tolerance in haemophilia A.
    Collins PW
    Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
    Machado P; Raya JM; Martín T; Morabito L; Brito ML; Rodríguez-Martín JM
    Int J Hematol; 2008 Jun; 87(5):545-549. PubMed ID: 18414981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor development in patients with hemophilia: an overview.
    Leissinger CA
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S1-2. PubMed ID: 16690370
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete immunotolerance induction after FEIBA prophylaxis in a haemophilia A patient with high-titre inhibitor.
    Nanishi E; Ohga S; Doi T; Ishimura M; Ihara K; Takada H; Shima M; Hara T
    Haemophilia; 2012 May; 18(3):e75-7. PubMed ID: 22404696
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein.
    Groomes CL; Gianferante DM; Crouch GD; Parekh DS; Scott DW; Lieuw K
    Pediatr Blood Cancer; 2016 May; 63(5):922-4. PubMed ID: 26739399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.
    Bidlingmaier C; Kurnik K; Escuriola-Ettingshausen C; Jager R; Klamroth R; Male C; Marosi A; Nemes L; von Stackelberg A; Kreuz W
    Haemophilia; 2011 Sep; 17(5):e837-40. PubMed ID: 21649797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.